Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Orthopediatrics (KIDS) over the last 7 years, with Q3 2025 value amounting to $23.6 million.

  • Orthopediatrics' Shares Outstanding (Diluted Average) rose 170.27% to $23.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.6 million, marking a year-over-year increase of 170.27%. This contributed to the annual value of $23.1 million for FY2024, which is 177.38% up from last year.
  • As of Q3 2025, Orthopediatrics' Shares Outstanding (Diluted Average) stood at $23.6 million, which was up 170.27% from $23.5 million recorded in Q2 2025.
  • Over the past 5 years, Orthopediatrics' Shares Outstanding (Diluted Average) peaked at $23.6 million during Q3 2025, and registered a low of $19.2 million during Q1 2021.
  • Over the past 5 years, Orthopediatrics' median Shares Outstanding (Diluted Average) value was $22.7 million (recorded in 2023), while the average stood at $21.7 million.
  • Per our database at Business Quant, Orthopediatrics' Shares Outstanding (Diluted Average) soared by 1690.45% in 2021 and then skyrocketed by 86.81% in 2022.
  • Over the past 5 years, Orthopediatrics' Shares Outstanding (Diluted Average) (Quarter) stood at $19.3 million in 2021, then rose by 8.72% to $20.9 million in 2022, then rose by 8.25% to $22.7 million in 2023, then increased by 1.77% to $23.1 million in 2024, then grew by 2.11% to $23.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $23.6 million in Q3 2025, compared to $23.5 million in Q2 2025 and $23.2 million in Q1 2025.